Crushing/Dissolving HIV Medications Effective in Hospitals

Providing dissolved or crushed bictegravir-emtricitabine-tenofovir alafenamide through an enteral tube can achieve ...

AUGUST 19, 2025

Trial Shows Lenacapavir + bNAbs As Possible HIV Treatment

New longer-acting treatment options for HIV may be on the horizon.

JULY 31, 2025

Study Finds 1 INSTI Combo Fares Better With Weight Gain

How do you pick which drug to prescribe for your patients with HIV?

MARCH 26, 2025

Good Results With Biktarvy in HIV–HBV Coinfection

At CROI 2025, Dr. Anchalee Avihingsanon and her colleagues reported Week 48 outcomes from the open-label extension ...

MARCH 25, 2025

Real-World Data Show Continued Virologic Suppression With Cabenuva

At CROI 2025, new research has shown high rates of continued virologic suppression with cabotegravir-rilpivirine ...

MARCH 25, 2025

Co-Circulating Viruses Causing Concern in Mpox Outbreak

Surveillance in Uganda has found co-circulating viruses, particularly varicella-zoster virus and mpox, with one ...

MARCH 13, 2025

Although Safe, Tecovirimat Proves Ineffective for Treating Clade II Mpox

More data from the STOMP trial presented at CROI 2025, held in San Francisco, confirms that tecovirimat does not ...

MARCH 13, 2025

Ensitrelvir Reduced the Risk for COVID-19 by 67%

Ensitrelvir, an antiretroviral being developed to prevent COVID-19, reduced the risk of developing the infection by ...

MARCH 13, 2025